So-Young International Inc. Annual Report: A Simple Breakdown

I’ve put together this guide to help you understand how So-Young International performed this year. Think of this as a plain-English breakdown to help you decide if this company fits your investment goals.

1. What does this company do?

So-Young runs a leading online platform for medical aesthetics in China. It acts as a two-sided marketplace where consumers use the app to find information, read reviews, and book appointments, while clinics and hospitals use the platform to market their services.

The company is also becoming a "one-stop shop." It now sells medical equipment and supplies directly to clinics. This allows them to generate revenue from both the consumer’s search journey and the clinic’s supply chain.

2. The "VIE" Structure: What You’re Actually Buying

It is vital to know that when you buy So-Young stock, you are not buying a piece of the actual Chinese business. Because China restricts foreign ownership in internet and medical firms, So-Young uses a "Variable Interest Entity" (VIE) structure.

You are buying shares in a Cayman Islands holding company. This company has contracts with the Chinese businesses that give the Cayman entity control and the right to the profits. If the Chinese government decides these contracts are invalid, the link between the Cayman entity and the Chinese operations could be severed, which would impact the value of your investment.

3. Financial Health & The "Cash Flow" Maze

The company moves money from its Chinese operations to the Cayman Islands through a specific legal framework.

• The Money Flow: The Chinese businesses pay "service fees" to the company’s Chinese subsidiaries. In 2025, these fees totaled $27 million, down from $32 million in 2024. This change reflects the current volatility within the medical aesthetics market.
• The "Leakage": Moving money to shareholders involves specific costs. China charges a 10% tax on dividends sent out of the country. Additionally, Chinese law requires the company to set aside 10% of its profit into a reserve fund, which remains within the Chinese operations.

4. Major Wins and Challenges

• The Win: They are successfully building a "one-stop shop." By supplying lasers and equipment, they are now deeply embedded in the industry, allowing them to earn money beyond simple advertising fees.
• The Challenge: The company manages a massive web of subsidiaries. This complex structure makes it difficult for investors to track the specific performance of individual business units.

5. Key Risks

• Regulatory Risk: The Chinese government maintains authority over the company and can change rules regarding data privacy or medical advertising at any time.
• The "Audit" Risk: The company currently passes U.S. inspections of their auditors, but this status is reviewed annually. Failure to maintain this compliance could lead to being delisted from U.S. stock exchanges.
• Competition: Social media giants are moving into the "beauty discovery" market. These competitors often have larger user bases and deeper pockets, which could increase the cost for So-Young to acquire new customers.

6. The Bottom Line

So-Young is a leader in a growing niche, but it comes with a "complexity tax." You aren't just betting on the beauty industry; you are betting that the legal structure remains stable, that the company can successfully navigate the transfer of cash out of China, and that they can defend their market share against much larger rivals.

Decision Checklist:

• Risk Tolerance: Are you comfortable with the legal uncertainties of a VIE structure?
• Market Outlook: Do you believe the medical aesthetics market in China will continue to grow despite increased competition?
• Long-term View: Does the company's shift toward supplying equipment provide enough of a competitive moat to justify the investment?